Air Liquide — Capital/Financing Update 2016

Jan 11, 2016

Paris, January 8, 2016

Semi-annual update on the AIR LIQUIDE liquidity contract

Under the liquidity contract entered into between AIR LIQUIDE and EXANE BNP PARIBAS, the following resources were listed in the liquidity account on December 31, 2015 (trading date):

• 3, 375 AIR LIQUIDE shares
• 30,326,508 €

As at June 30, 2015, the most recent update, the following resources had been allocated to the liquidity account:

• AIR LIQUIDE no share position
• 30,788,876 €

CONTACTS

Corporate Communications Anne Bardot +33 (0)1 40 62 53 34 Annie Fournier +33 (0)1 40 62 57 18

Investor Relations

Aude Rodriguez +33 (0)1 40 62 57 08 Louis Laffont +33 (0)1 40 62 57 18 Shareholder Services Patrick Renard +33 (0)1 40 62 51 86 Didier Henriot +33 (0)1 40 62 52 89

World leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with more than 50,000 employees and serves more than 2 million customers and patients. Oxygen, nitrogen and hydrogen have been at the core of the company's activities since its creation in 1902. Air Liquide's ambition is to be the leader in its industry, delivering long-term performance and acting responsibly.

Air Liquide ideas create value over the long term. At the core of the company's development are the commitment and constant inventiveness of its people.

Air Liquide anticipates the challenges of its markets, invests locally and globally, and delivers high-quality solutions to its customers and patients, and the scientific community.

The company relies on competitiveness in its operations, targeted investments in growing markets and innovation to deliver profitable growth over the long-term.

Air Liquide's revenues amounted to € 15.4 billion in 2014, and its solutions that protect life and the environment represented around 40% of sales. Air Liquide is listed on the Paris Euronext stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones Euro Stoxx 50 indexes.